Fengliaoxing Baoji Wan
Natural health product licensed in Canada
If this product were sold in France
- Conditions légales
Trichosanthes kirilowii Maxim.: L'absence de trichosanthine doit être prouvée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pogostemon cablin Source : Plante entière | 251.6 mg | Not calculated |
| Trichosanthes kirilowii Source : Racine | 188.8 mg | Not calculated |
| Chrysanthemum x morifolium Source : Fleur | 125.8 mg | Not calculated |
| Coix lacryma-jobi var. ma-yuen Source : Graine(s) | 314.6 mg | Not calculated |
Non-medicinal ingredients
Talc, CI Natural Red 4, Dextrine, Amidon de blé, Oxyde de fer (Fe2O3)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Sachet de thé | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditional Chinese Medicine to expel dampness and harmonize the middle energizer, use for stomach pain and diarrhea, nausea, vomiting, discomfort in the stomach and intestines, indigestion, seasonal common cold, fever, headache , and motion sickness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Baoji for common cold, Fengliaoxing Baoji Pills, Fengliaoxing Baoji medicine
- Licence holder
- Richwin Toronto Corporation
- NPN or DIN-HM
- 80041636
- Status
- Active licence
- Licence date
- 12 April 2013
- Revision date
- 7 March 2023
- Form
- Sachet de thé
- Route of administration
- Orale
- Application type
- Traditionnelle
Source
Official Health Canada record, licence 80041636
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Fengliaoxing Baoji Wan (Richwin Toronto Corporation): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80041636-fengliaoxing-baoji-wan, updated 7 March 2023.